135 related articles for article (PubMed ID: 15793784)
1. [Screening 21-hydroxylase deficiency carriers in androgen excess women of Chinese Han nationality].
Tao H; Lu Z; Zhang B; Wang Y; Sun M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):195-7. PubMed ID: 15793784
[TBL] [Abstract][Full Text] [Related]
2. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.
Admoni O; Israel S; Lavi I; Gur M; Tenenbaum-Rakover Y
Clin Endocrinol (Oxf); 2006 Jun; 64(6):645-51. PubMed ID: 16712666
[TBL] [Abstract][Full Text] [Related]
3. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations.
Escobar-Morreale HF; San Millán JL; Smith RR; Sancho J; Witchel SF
Fertil Steril; 1999 Oct; 72(4):629-38. PubMed ID: 10521100
[TBL] [Abstract][Full Text] [Related]
4. Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status.
Dolzan V; Prezelj J; Vidan-Jeras B; Breskvar K
Eur J Endocrinol; 1999 Aug; 141(2):132-9. PubMed ID: 10427156
[TBL] [Abstract][Full Text] [Related]
5. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.
Knochenhauer ES; Cortet-Rudelli C; Cunnigham RD; Conway-Myers BA; Dewailly D; Azziz R
J Clin Endocrinol Metab; 1997 Feb; 82(2):479-85. PubMed ID: 9024240
[TBL] [Abstract][Full Text] [Related]
6. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese.
Lee HH; Kuo JM; Chao HT; Lee YJ; Chang JG; Tsai CH; Chung BC
J Clin Endocrinol Metab; 2000 Feb; 85(2):597-600. PubMed ID: 10690861
[TBL] [Abstract][Full Text] [Related]
7. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
[TBL] [Abstract][Full Text] [Related]
8. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
[TBL] [Abstract][Full Text] [Related]
9. Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency.
Török D; Halász Z; Garami M; Homoki J; Fekete G; Sólyom J
Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):27-32. PubMed ID: 12605347
[TBL] [Abstract][Full Text] [Related]
10. Identification of heterozygotic carriers of 21-hydroxylase deficiency: sensitivity of ACTH stimulation tests.
Witchel SF; Lee PA
Am J Med Genet; 1998 Apr; 76(4):337-42. PubMed ID: 9545098
[TBL] [Abstract][Full Text] [Related]
11. Correlation between genotype and hormonal levels in heterozygous mutation carriers and non-carriers of 21-hydroxylase deficiency.
Napolitano E; Manieri C; Restivo F; Composto E; Lanfranco F; Repici M; Pasini B; Einaudi S; Menegatti E
J Endocrinol Invest; 2011; 34(7):498-501. PubMed ID: 20671415
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia.
Dolzan V; Sólyom J; Fekete G; Kovács J; Rakosnikova V; Votava F; Lebl J; Pribilincova Z; Baumgartner-Parzer SM; Riedl S; Waldhauser F; Frisch H; Stopar-Obreza M; Krzisnik C; Battelino T
Eur J Endocrinol; 2005 Jul; 153(1):99-106. PubMed ID: 15994751
[TBL] [Abstract][Full Text] [Related]
13. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
14. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
[TBL] [Abstract][Full Text] [Related]
15. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Bachega TA; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2000 May; 52(5):601-7. PubMed ID: 10792340
[TBL] [Abstract][Full Text] [Related]
16. The frequency of CYP 21 gene mutations in Turkish women with hyperandrogenism.
Kelestimur F; Everest H; Dundar M; Tanriverdi F; White C; Witchel SF
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):205-8. PubMed ID: 19085698
[TBL] [Abstract][Full Text] [Related]
17. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
18. Carriers for type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) deficiency can only be identified by HSD3B2 genotype study and not by hormone test.
Pang S; Carbunaru G; Haider A; Copeland KC; Chang YT; Lutfallah C; Mason JI
Clin Endocrinol (Oxf); 2003 Mar; 58(3):323-31. PubMed ID: 12608938
[TBL] [Abstract][Full Text] [Related]
19. Mutations in steroid 21-hydroxylase (CYP21).
White PC; Tusie-Luna MT; New MI; Speiser PW
Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
[TBL] [Abstract][Full Text] [Related]
20. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency.
Witchel SF; Lee PA; Suda-Hartman M; Hoffman EP
Biochem Mol Med; 1997 Dec; 62(2):151-8. PubMed ID: 9441866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
